Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538262 · ClinicalTrials.gov registry record
Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 226
- Enrollment target
NCT03538262: Completed study, sponsored by Massachusetts General Hospital.
NCT03538262 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 226 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538262 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 226 participants
- Enrollment target
Study Summary
An observational study to characterize and compare long-term clinical outcomes data collected remotely through periodic tele-visits, interactive smartphone app sessions, and web-based surveys in individuals with Parkinson's Disease (PD) who have completed the interventional phases of the STEADY-PD3 and SURE-PD3 clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2022-03-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03538262
The ClinicalTrials.gov registry entry for NCT03538262 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03538262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03538262 about?
NCT03538262 is a clinical study titled "Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials". An observational study to characterize and compare long-term clinical outcomes data collected remotely through periodic tele-visits, interactive smartphone app sessions, and web-based surveys in individuals with Parkinson's Disease (PD) who have completed the interventional phases of the STEADY-PD3 ...
What is the current status of trial NCT03538262?
This trial is currently completed. The enrollment target is 226 participants. The study started on 2018-10-01. Estimated completion is 2022-03-21.
Who is sponsoring clinical trial NCT03538262?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.